Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples